Related references
Note: Only part of the references are listed.Targeting Nitric Oxide Signaling with nNOS Inhibitors As a Novel Strategy for the Therapy and Prevention of Human Melanoma
Zhen Yang et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
The yin and yang of nitric oxide in cancer progression
Amy J. Burke et al.
CARCINOGENESIS (2013)
Molecular Pathways: Inflammation-Associated Nitric-Oxide Production as a Cancer-Supporting Redox Mechanism and a Potential Therapeutic Target
Elizabeth A. Grimm et al.
CLINICAL CANCER RESEARCH (2013)
Functional involvement of β3-adrenergic receptors in melanoma growth and vascularization
Massimo Dal Monte et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
L-Theanine promotes nitric oxide production in endothelial cells through eNOS phosphorylation
Jamila H. Siamwala et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2013)
Beta3-adrenergic receptors modulate vascular endothelial growth factor release in response to hypoxia through the nitric oxide pathway in mouse retinal explants
Massimo Dal Monte et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2013)
Effect of β-Blockers and Other Antihypertensive Drugs On the Risk of Melanoma Recurrence and Death
Vincenzo De Giorgi et al.
MAYO CLINIC PROCEEDINGS (2013)
β-Adrenergic system, a backstage manipulator regulating tumour progression and drug target in cancer therapy
Jing Tang et al.
SEMINARS IN CANCER BIOLOGY (2013)
Beta3-Adrenoreceptors in Cardiovasular Diseases: New Roles for an Old Receptor
Jean-Luc Balligand
CURRENT DRUG DELIVERY (2013)
The essential role for aromatic cluster in the β3 adrenergic receptor
Hai-yan Cai et al.
ACTA PHARMACOLOGICA SINICA (2012)
Changes in eNOS phosphorylation contribute to increased arteriolar NO release during juvenile growth
Lori S. Kang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2012)
b-adrenergic-blocking drugs and melanoma: current state of the art
Vincenzo De Giorgi et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2012)
Role of endothelial nitric oxide synthase (eNOS) in chronic stress-promoted tumour growth
Antonio Barbieri et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
Anti-inflammatory and anti-tumor activity of the marine mangrove Rhizophora apiculata
V. Vinod Prabhu et al.
JOURNAL OF IMMUNOTOXICOLOGY (2012)
A novel mechanism of coenzyme Q10 protects against human endothelial cells from oxidative stress-induced injury by modulating NO-related pathways
Kun-Ling Tsai et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2012)
β-Blockers and Survival among Danish Patients with Malignant Melanoma: A Population-Based Cohort Study
Stanley Lemeshow et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Nitric oxide signaling: Classical, less classical, and nonclassical mechanisms
Antonio Martinez-Ruiz et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Leptin promotes melanoma tumor growth in mice related to increasing circulating endothelial progenitor cells numbers and plasma NO production
Fatemehsadat Amjadi et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy
Soraya I. de Oliveira et al.
BMC CANCER (2010)
Targeted Inhibition of Inducible Nitric Oxide Synthase Inhibits Growth of Human Melanoma In vivo and Synergizes with Chemotherapy
Andrew G. Sikora et al.
CLINICAL CANCER RESEARCH (2010)
Beta3-Adrenoceptor Agonists: Possible Role in the Treatment of Overactive Bladder
Yasuhiko Igawa et al.
KOREAN JOURNAL OF UROLOGY (2010)
Catecholamines Relax Detrusor through beta(2)-Adrenoceptors in Mouse and beta(3)-Adrenoceptors in Man
Melinda Wuest et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Nitric oxide-mediated modulation of calcium/calmodulin-dependent protein kinase II
Tao Song et al.
BIOCHEMICAL JOURNAL (2008)
Protective effects of lipopolysaccharide preconditioning against nitric oxide neurotoxicity
Chia-Yen Huang et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
Constitutive intracellular production of iNOS and NO in human melanoma: possible role in regulation of growth and resistance to apoptosis
Elizabeth A. Grimm et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2008)
Tools to study β3-adrenoceptors
Wim Vrydag et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2007)
S-nitrosylation of Bcl-2 inhibits its ubiquitin-proteasomal degradation -: A novel antiapoptotic mechanism that suppresses apoptosis
Neelam Azad et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Tumor iNOS predicts poor survival for stage III melanoma patients
Suhendan Ekmekcioglu et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Tumoristatic effects of anti-CD40 mAb-activated macrophages involve nitric oxide and tumour necrosis factor-α
Hillary D. Lum et al.
IMMUNOLOGY (2006)
Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in human malignant melanoma and their relation to angiogenesis
YT Tu et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2006)
β-adrenergic receptors and nitric oxide generation in the cardiovascular system
L. R. Queen et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Nitric oxide production from rat adipocytes is modulated by β3-adrenergic receptor agonists and is involved in a cyclic AMP-dependent lipolysis in adipocytes
NK Canová et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2006)
Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells
M Fraser et al.
ONCOGENE (2006)
Comparative pharmacology of human β-adrenergic receptor subtypes -: characterization of stably transfected receptors in CHO cells
C Hoffmann et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2004)
Depletion of endogenous nitric oxide enhances cisplatin-induced apoptosis in a p53-dependent manner in melanoma cell lines
CH Tang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Apoptosis protease activator protein-1 expression is dispensable for response of human melanoma cells to distinct proapoptotic agents
M Zanon et al.
CANCER RESEARCH (2004)
Effects of two β3-agonists, CGP 12177A and BRL 37344, on coronary flow and contractility in isolated guinea pig heart
VI Kozlovski et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2003)
The preferential β3-adrenoceptor agonist BRL 37344 increases force via β1-/β2-adrenoceptors and induces endothelial nitric oxide synthase via β3-adrenoceptors in human atrial myocardium
C Pott et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Inhibition of heat shock protein 90 (hsp90) in proliferating endothelial cells uncouples endothelial nitric oxide synthase activity
J Ou et al.
FREE RADICAL BIOLOGY AND MEDICINE (2003)
Induction of matrix metalloproteinase gene transcription by nitric oxide and mechanisms of MMP-1 gene induction in human melanoma cell lines
Y Ishii et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Functional interaction of endothelial nitric oxide synthase with a voltage-dependent anion channel
JX Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Role of β3-adrenergic receptors in the action of a tumour lipid mobilizing factor
ST Russell et al.
BRITISH JOURNAL OF CANCER (2002)
Inhibition of neuronal nitric oxide synthase activity by 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e), a novel neuroprotective agent, in vitro and in cultured neuroblastoma cells in situ
K Fukunaga et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Share Paper
